Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 4.17
- Piotroski Score 6.00
- Grade Outperform
- Symbol (BIO)
- Company Bio-Rad Laboratories, Inc.
- Price $373.53
- Changes Percentage (0.16%)
- Change $0.6
- Day Low $369.91
- Day High $377.46
- Year High $387.99
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $482.50
- High Stock Price Target $565.00
- Low Stock Price Target $400.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$10.69
- Trailing P/E Ratio -26.85
- Forward P/E Ratio -26.85
- P/E Growth -26.85
- Net Income $-637,324,000
Income Statement
Quarterly
Annual
Latest News of BIO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
Terry Rosen, CEO, discussed the direct move to human studies without preclinical work with Fallu and CA. Atrumid program's next steps are being planned post ARC nine data. The strategy for IO-naive re...
By Yahoo! Finance | 18 hours ago -
Blue Shield Of California Push For Cheaper Biosimilars Could Disrupt Market
Blue Shield of California is offering a biosimilar of Humira, called Idacio, at a low price of $525, bypassing traditional pharmacy benefit managers. This move aims to reduce costs for patients and ma...
By Forbes | 1 day ago -
Gilead's earnings beat by a wide margin, and biotech raises guidance
Gilead Sciences Inc. saw a 2% rise in stock during after-hours trading following strong Q3 earnings and increased guidance, driven by high demand for its HIV and COVID-19 treatments. Net income was $1...
By MarketWatch | 1 day ago
